Showing posts with label institutional conflicts of interest. Show all posts
Showing posts with label institutional conflicts of interest. Show all posts

Friday, May 15, 2015

A Call to Restore the Integrity of Clinical Research - but Will Anyone Heed it?

Concerns about suppression and manipulation of clinical research to serve vested interests have finally gotten a little more mainstream. ...
A Call to Restore the Integrity of Clinical Research - but Will Anyone Heed it? Rating: 4.5 Diposkan Oleh: Unknown

Monday, May 11, 2015

Our Man in the NQF? - CareFusion Settles Kickback Allegations for $40.1 Million and Government Alleges They Meant to Manipulate National Quality Forum Standards

What appeared to be yet another entry in the march of legal settlements turns out to be more interesting than it first appeared. The Basi...
Our Man in the NQF? - CareFusion Settles Kickback Allegations for $40.1 Million and Government Alleges They Meant to Manipulate National Quality Forum Standards Rating: 4.5 Diposkan Oleh: Unknown

Putting in the Ski Lifts - National Quality Forum Leaders Improve Conflict of Interest Policies in Response to CareFusion Case

The complex case that came to light with reports of a legal settlement by CareFusion of allegations that it paid kickbacks to promote its Ch...
Putting in the Ski Lifts - National Quality Forum Leaders Improve Conflict of Interest Policies in Response to CareFusion Case Rating: 4.5 Diposkan Oleh: Unknown

The CareFusion/ Denham/ NQF Case - the Plot Thickens

The story about CareFusion, its financial relationships with Dr Charles Denham, and his alleged role in promoting a CareFusion product throu...
The CareFusion/ Denham/ NQF Case - the Plot Thickens Rating: 4.5 Diposkan Oleh: Unknown

Thursday, January 3, 2013

Oh, the Prices we Pay ... for Questionable Drug Marketing to Enrich Corporate Insiders - the Case of Questcor's H P Acthar Revisited

In 2007, we first discussed the case of the amazing pricing of H P Acthar, a very old drug of questionable usefulness, as an example of the...
Oh, the Prices we Pay ... for Questionable Drug Marketing to Enrich Corporate Insiders - the Case of Questcor's H P Acthar Revisited Rating: 4.5 Diposkan Oleh: Unknown

Thursday, December 6, 2012

The Parts of Professionalism We Are Not Supposed to Discuss

A recent article in a a relatively obscure medical ethics journal dared to approach some important aspects of medical ethics that medical et...
The Parts of Professionalism We Are Not Supposed to Discuss Rating: 4.5 Diposkan Oleh: Unknown